Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation.
Domenico AngellottiRachele ManzoDomenico Simone CastielloRaffaele PiccoloMarisa AvvedimentoAttilio LeoneFederica IlardiAndrea MarianiCristina IapiccaLuigi Di SerafinoPlinio CirilloAnna FranzoneGiovanni EspositoPublished in: Acta cardiologica (2022)
Comparative analysis of early clinical outcomes showed that COVID-19 pandemic did not affect the safety and effectiveness of TAVI as similar rates of procedural complications and all-cause mortality were reported than before February 2020. Despite the increased time lag between diagnosis and procedure and a more complex clinical profile of patients at baseline, the revised pathway of hospitalisation allowed to resume inpatient procedures while not affecting patients' and healthcare workers' safety.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- ejection fraction
- aortic valve
- aortic valve replacement
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- systematic review
- transcatheter aortic valve replacement
- mental health
- peritoneal dialysis
- palliative care
- heart failure
- patient reported outcomes
- acute care